270 related articles for article (PubMed ID: 25085663)
1. Current status and future directions of molecularly targeted therapies and immunotherapies for melanoma.
Miller DM; Flaherty KT; Tsao H
Semin Cutan Med Surg; 2014 Jun; 33(2):60-7. PubMed ID: 25085663
[TBL] [Abstract][Full Text] [Related]
2. Systemic Therapies for Advanced Melanoma.
Bomar L; Senithilnathan A; Ahn C
Dermatol Clin; 2019 Oct; 37(4):409-423. PubMed ID: 31466582
[TBL] [Abstract][Full Text] [Related]
3. Combinatorial Therapies in Melanoma: MAPK Inhibitors and Beyond.
Zhou AY; Johnson DB
Am J Clin Dermatol; 2018 Apr; 19(2):181-193. PubMed ID: 28861871
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms and strategies to overcome resistance to molecularly targeted therapy for melanoma.
Lim SY; Menzies AM; Rizos H
Cancer; 2017 Jun; 123(S11):2118-2129. PubMed ID: 28543695
[TBL] [Abstract][Full Text] [Related]
5. Combination of Immunotherapy With Targeted Therapy: Theory and Practice in Metastatic Melanoma.
Yu C; Liu X; Yang J; Zhang M; Jin H; Ma X; Shi H
Front Immunol; 2019; 10():990. PubMed ID: 31134073
[TBL] [Abstract][Full Text] [Related]
6. Management of Metastatic Melanoma in 2018.
Kaufman HL; Margolin K; Sullivan R
JAMA Oncol; 2018 Jun; 4(6):857-858. PubMed ID: 29621376
[No Abstract] [Full Text] [Related]
7. Update on systemic therapy for advanced cutaneous melanoma and recent development of novel drugs.
Swe T; Kim KB
Clin Exp Metastasis; 2018 Aug; 35(5-6):503-520. PubMed ID: 30019239
[TBL] [Abstract][Full Text] [Related]
8. Interaction of molecular alterations with immune response in melanoma.
Szczepaniak Sloane RA; Gopalakrishnan V; Reddy SM; Zhang X; Reuben A; Wargo JA
Cancer; 2017 Jun; 123(S11):2130-2142. PubMed ID: 28543700
[TBL] [Abstract][Full Text] [Related]
9. Combination Therapies for Melanoma: A New Standard of Care?
Smalley KS; Eroglu Z; Sondak VK
Am J Clin Dermatol; 2016 Apr; 17(2):99-105. PubMed ID: 26860106
[TBL] [Abstract][Full Text] [Related]
10. Conjunctival Melanoma: Current Treatments and Future Options.
Grimes JM; Shah NV; Samie FH; Carvajal RD; Marr BP
Am J Clin Dermatol; 2020 Jun; 21(3):371-381. PubMed ID: 31965542
[TBL] [Abstract][Full Text] [Related]
11. Molecularly targeted therapies for melanoma.
Liu LS; Colegio OR
Int J Dermatol; 2013 May; 52(5):523-30. PubMed ID: 23590367
[TBL] [Abstract][Full Text] [Related]
12. [Genetic diversity and immunological characteristics of malignant melanoma: the therapeutic spectrum].
Doma V; Gulya E
Orv Hetil; 2015 Apr; 156(15):583-91. PubMed ID: 25845317
[TBL] [Abstract][Full Text] [Related]
13. Metastatic melanoma treatment: Combining old and new therapies.
Davey RJ; van der Westhuizen A; Bowden NA
Crit Rev Oncol Hematol; 2016 Feb; 98():242-53. PubMed ID: 26616525
[TBL] [Abstract][Full Text] [Related]
14. New treatments for cutaneous metastatic melanoma: MAPK pathway-targeted and immune based therapies.
Ranchon F; Boespflug A; Rioufol C; Schwiertz V; Thomas L; Dalle S
Anticancer Agents Med Chem; 2015; 15(4):461-7. PubMed ID: 25553438
[TBL] [Abstract][Full Text] [Related]
15. Targeting oncogenic drivers and the immune system in melanoma.
McArthur GA; Ribas A
J Clin Oncol; 2013 Feb; 31(4):499-506. PubMed ID: 23248252
[TBL] [Abstract][Full Text] [Related]
16. Systemic therapy for previously untreated advanced BRAF-mutated melanoma: navigating a shifting landscape.
Levine O; Devji T; Xie F
Immunotherapy; 2017 Mar; 9(5):375-378. PubMed ID: 28357918
[No Abstract] [Full Text] [Related]
17. No longer an untreatable disease: how targeted and immunotherapies have changed the management of melanoma patients.
Girotti MR; Saturno G; Lorigan P; Marais R
Mol Oncol; 2014 Sep; 8(6):1140-58. PubMed ID: 25178978
[TBL] [Abstract][Full Text] [Related]
18. Update on Immunotherapeutics in the Management of Metastatic Melanoma.
Bulir D; Liang S; O’Malley M; McWhirter E
Skin Therapy Lett; 2019 Jan; 24(1):8-11. PubMed ID: 30817881
[TBL] [Abstract][Full Text] [Related]
19. Survival of melanoma patients treated with targeted therapy and immunotherapy after systematic upfront control of brain metastases by radiosurgery.
Gaudy-Marqueste C; Dussouil AS; Carron R; Troin L; Malissen N; Loundou A; Monestier S; Mallet S; Richard MA; Régis JM; Grob JJ
Eur J Cancer; 2017 Oct; 84():44-54. PubMed ID: 28783540
[TBL] [Abstract][Full Text] [Related]
20. Recent developments in the medical and surgical treatment of melanoma.
Saranga-Perry V; Ambe C; Zager JS; Kudchadkar RR
CA Cancer J Clin; 2014; 64(3):171-85. PubMed ID: 24676837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
